LYRIC PHARMACEUTICALS INC.
Profile
Company Names
LYRIC PHARMACEUTICALS INC.
Addresses
601 GATEWAY BLVD., SUITE 1020, SOUTH SAN FRANCISCO, CA 94080
Phone Numbers
415 277-5437
Entity Type:
CORPORATION
Industry:
PHARMACEUTICALS
Year Incorporated:
2013
State Incorporated:
DELAWARE
Total Amount Raised:
$26,785,593.00
Number of Funding Rounds:
1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2015-02-11
$26,785,593.00
$33,885,598.00
$7,100,005.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
CASEY
CUNNINGHAM
DIRECTOR
JASON
HONG
DIRECTOR
KEVIN
LALANDE
DIRECTOR
HOSPITALISTS NOW, INC.
| D5 PHARMA, INC.
| TERAPIO CORP
| SPINAL RESTORATION INC
| ZENO CORP
| MOLECULAR TEMPLATES, INC.
| LDR HOLDING CORP
| CHANRX CORP.
| LYRIC PHARMACEUTICALS INC.
| LAGUNA PHARMACEUTICALS, INC.
| SANTE CAPITAL FUND, LP
| CLAIRITY, INC.
| SENSORIUM THERAPEUTICS, INC.
| MOLECULAR TEMPLATES, INC.
NIALL
O-DONNELL
DIRECTOR
LYRIC PHARMACEUTICALS INC.
| 3X5 RIVERVEST FUND II, L.P.
| ARCHER SEED FUND, L.P.
| GENOA PHARMACEUTICALS, INC.
| RENEO PHARMACEUTICALS, INC.
| RIVERVEST VENTURE FUND IV, L.P.
| CURZION PHARMACEUTICALS, INC.
| SPRUCE BIOSCIENCES, INC.
| AVALYN PHARMA INC.
| MIRUM PHARMACEUTICALS, INC.
| RIVERVEST VENTURE FUND V, L.P.
| SPARROW PHARMACEUTICALS, INC.
| WUGEN, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

